Literature DB >> 12915917

Canadian Association of Gastroenterology - Canadian Institutes of Health Research - pharmaceutical partner postdoctoral operating fellowship programme: an outstanding success that continues to excel!

Derek M McKay1, Sandra Daniels.   

Abstract

The Canadian Association of Gastroenterology (CAG) postdoctoral fellowship programme was initiated in 1992 with the goal of promoting excellence in Canadian gastroenterological research. With backing from multiple pharmaceutical partners and the Canadian Institutes of Health Research, 87 fellows were funded over the next ten years for a total investment of $8,730,101. Between 1992 and 2000, fellows authored 247 articles; 176 being original research articles, 31 (17.5%) of which appeared in journals with impact factors of greater than 10. As testament to the program's success in developing young scientists, 31 former fellows (36%) have progressed to faculty positions. The fellowship programme continues to be an outstanding success and the flagship of CAG research activities.

Mesh:

Year:  2003        PMID: 12915917     DOI: 10.1155/2003/189642

Source DB:  PubMed          Journal:  Can J Gastroenterol        ISSN: 0835-7900            Impact factor:   3.522


  2 in total

1.  Evaluation of funding gastroenterology research in Canada illustrates the beneficial role of partnerships.

Authors:  Philip M Sherman; Kimberly Banks Hart; Keeley L Rose; Kwadwo Bosompra; Christopher Manuel; Paul Belanger; Sandra Daniels; Paul Sinclair; Stephen Vanner; Andre Buret
Journal:  Can J Gastroenterol       Date:  2013-12       Impact factor: 3.522

2.  Measuring Success in Global Health Training: Data From 14 Years of a Postdoctoral Fellowship in Infectious Diseases and Tropical Medicine.

Authors:  Joseph D Tucker; Molly A Hughes; Ravi V Durvasula; Joseph M Vinetz; Victoria P McGovern; Rhonda Schultz; Claire Panosian Dunavan; Mary E Wilson; Danny A Milner; Regina C LaRocque; Stephen B Calderwood; Richard L Guerrant; Peter F Weller; Terrie E Taylor
Journal:  Clin Infect Dis       Date:  2017-06-15       Impact factor: 9.079

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.